The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma

Clinical Science

Volumn 121, Issue 10, 2011, Pages 437-447

  Zhang, Tengfei ^a   Wang, Qiming ^b   Zhao, Dan ^a,d   Cui, Yaling ^c   Cao, Bangrong ^a   Guo, Liping ^a   Lu, Shih Hsin ^a  

^a CANCER HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c Henan Tumor Hospital   (China)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Diagnosis; MicroRNA; MiR 31; Oesophageal squamous cell carcinoma (ESCC); Prognosis

Indexed keywords

EPITHELIAL MEMBRANE PROTEIN 1; KINASE SUPPRESSOR OF RAS 2; MEMBRANE PROTEIN; MICRORNA; MICRORNA 31; PHOSPHOTRANSFERASE; RGS4 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SURVIVAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; EPIDEMIOLOGIC METHODS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY; UP-REGULATION;

EID: 80052343196     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20110207     Document Type: Article

References (45)

1. Parkin, D. M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108
2. Holmes, R. S. and Vaughan, T. L. (2007) Epidemiology and pathogenesis of esophageal cancer. Semin. Radiat. Oncol. 17, 2-9
3. Urba, S. G., Orringer, M. B., Turrisi, A., Iannettoni, M., Forastiere, A. and Strawderman, M. (2001) Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J. Clin. Oncol. 19, 305-313
4. Kelsen, D. P., Ginsberg, R., Pajak, T. F., Sheahan, D. G., Gunderson, L., Mortimer, J., Estes, N., Haller, D. G., Ajani, J., Kocha, W. et al. (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N. Engl. J. Med. 339, 1979-1984
5. Bonnetain, F., Bouche, O., Michel, P., Mariette, C., Conroy, T., Pezet, D., Roullet, B., Seitz, J. F., Paillot, B., Arveux, P. et al. (2006) A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann. Oncol. 17, 827-834
6. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T. et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198
7. Ng, E. K., Chong, W.W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., Poon, T. C., Ng, S. S. and Sung, J. J. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 58, 1375-1381
8. Ventura, A. and Jacks, T. (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136, 586-591
9. Slaby, O., Svoboda, M., Fabian, P., Smerdova, T., Knoflickova, D., Bednarikova, M., Nenutil, R. and Vyzula, R. (2007) Altered expression of miR-21,miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72, 397-402
10. Zhang, Y., Guo, J., Li, D., Xiao, B., Miao, Y., Jiang, Z. and Zhuo, H. (2009) Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med. Oncol. 16, 360-364
11. Yan, L. X., Huang, X. F., Shao, Q., Huang, M. Y., Deng, L., Wu, Q. L., Zeng, Y. X. and Shao, J. Y. (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14, 2348-2360
12. Schaefer, A., Jung, M., Mollenkopf, H. J.,Wagner, I., Stephan, C., Jentzmik, F., Miller, K., Lein, M., Kristiansen, G. and Jung, K. (2010) Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int. J. Cancer 126, 1166-1176
13. Creighton, C. J., Fountain, M. D., Yu, Z., Nagaraja, A. K., Zhu, H., Khan, M., Olokpa, E., Zariff, A., Gunaratne, P. H., Matzuk, M. M. and Anderson, M. L. (2010) Molecular profiling uncovers a p53-associated role for micro-RNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. Cancer Res. 70, 1906-1915
14. Lajer, C. B., Nielsen, F. C., Friis-Hansen, L., Norrild, B., Borup, R., Garnaes, E., Rossing, M., Specht, L., Therkildsen, M. H., Nauntofte, B. et al. (2011) Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br. J. Cancer 104, 830-840
15. Wang, P., Fu, T.,Wang, X. and Zhu, W. (2010) Primary, study of miRNA expression pattens in laryngeal carcinoma by microarray. Lin Chung Er Bi Yan Hou Tou JingWai Ke Za Zhi 24, 535-538
16. Liu, X., Sempere, L. F., Ouyang, H., Memoli, V. A., Andrew, A. S., Luo, Y., Demidenko, E., Korc, M., Shi, W., Preis, M. et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J. Clin. Invest. 120, 1298-1309
17. Wong, T. S., Liu, X. B.,Wong, B. Y., Ng, R. W., Yuen, A. P. and Wei,W. I. (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin. Cancer Res. 14, 2588-2592
18. Hu, Z., Chen, X., Zhao, Y., Tian, T., Jin, G., Shu, Y., Chen, Y., Xu, L., Zen, K., Zhang, C. and Shen, H. (2010) Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol. 28, 1721-1726
19. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y.,Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X. et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell. Res. 18, 997-1006
20. Gilad, S., Meiri, E., Yogev, Y., Benjamin, S., Lebanony, D., Yerushalmi, N., Benjamin, H., Kushnir, M., Cholakh, H., Melamed, N. et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS ONE 3, e3148
21. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A. et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U.S.A. 105, 10513-10518
22. Lawrie, C. H., Gal, S., Dunlop, H. M., Pushkaran, B., Liggins, A. P., Pulford, K., Banham, A. H., Pezzella, F., Boultwood, J., Wainscoat, J. S. et al. (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141, 672-675
23. Edge, S. B., Byrd, D. R.,Compton,C.C., Fritz, A. G., Greene, F. L. and Trotti, A. (2010) American Joint Committee on Cancer: AJCC Cancer Staging Manual, 7th edn, p. 646, Springer, New York
24. Shi, R. and Chiang, V. L. (2005) Facile means for quantifying microRNA expression by real-time PCR. BioTechniques 39, 519-525
25. Han, Y., Wei, F., Xu, X., Cai, Y., Chen, B.,Wang, J., Xia, S., Hu, H., Huang, X., Wu, M. and Wang, M. (2002) Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 19, 455-457
26. Shimada, Y., Imamura, M., Wagata, T., Yamaguchi, N. and Tobe, T. (1992) Characterization of 21 newly established esophageal cancer cell lines. Cancer 69, 277-284
27. Huang, Z., Huang, D., Ni, S., Peng, Z., Sheng, W. and Du, X. (2009) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 127, 118-126
28. Liu,C. J., Kao, S. Y., Tu, H. F., Tsai,M.M., Chang, K. W. and Lin, S. C. (2010) Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Oral Dis. 70, 1635-1644
29. Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szasz, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L. and Weinberg, R. A. (2009) A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046
30. Aprelikova, O., Yu, X., Palla, J.,Wei, B. R., John, S., Yi, M., Stephens, R., Simpson, R. M., Risinger, J. I., Jazaeri, A. and Niederhuber, J. (2010) The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts. Cell Cycle 9, 4387-4398
31. Tsai, Y. H., Wu, M. F., Wu, Y. H., Chang, S. J., Lin, S. F., Sharp, T. V. and Wang, H. W. (2009) The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J. Virol. 83, 622-632
32. Chen, Y., Medvedev, A., Ruzanov, P., Marvin, K. W. and Jetten, A. M. (1997) cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family. Genomics 41, 40-48
33. Liu, L., Channavajhala, P. L., Rao, V. R., Moutsatsos, I., Wu, L., Zhang, Y., Lin, L. L. and Qiu, Y. (2009) Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim. Biophys. Acta 1794, 1485-1495
34. Channavajhala, P. L., Rao, V. R., Spaulding, V., Lin, L. L. and Zhang, Y. G. (2005) hKSR-2 inhibits MEKK3-activated MAP kinase and NF-κB pathways in inflammation. Biochem. Biophys. Res. Commun. 334, 1214-1218
35. Dougherty, M. K., Ritt, D. A., Zhou, M., Specht, S. I., Monson, D. M., Veenstra, T. D. and Morrison, D. K. (2009) KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Mol. Cell 34, 652-662
36. Niedergethmann, M., Alves, F., Neff, J. K., Heidrich, B., Aramin, N., Li, L., Pilarsky, C., Grutzmann, R., Allgayer, H., Post, S. and Gretz, N. (2007) Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br. J. Cancer 97, 1432-1440
37. Xie, Y., Wolff, D.W., Wei, T., Wang, B., Deng, C., Kirui, J. K., Jiang, H., Qin, J., Abel, P. W. and Tu, Y. (2009) Breast cancer migration and invasion depend on proteasome degradation of regulator of G-protein signaling 4. Cancer Res. 69, 5743-5751
38. Puiffe, M. L., Le Page, C., Filali-Mouhim, A., Zietarska, M., Ouellet, V., Tonin, P. N., Chevrette, M., Provencher, D. M. and Mes-Masson, A. M. (2007) Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 9, 820-829
39. Tatenhorst, L., Senner, V., Puttmann, S. and Paulus, W. (2004) Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility. J. Neuropathol. Exp. Neurol. 63, 210-222
40. Wang, H. T., Liu, Z. H., Wang, X. Q. and Wu, M. (2002) Effect of EMP-1 gene on human esophageal cancer cell line. Ai Zheng 21, 229-232
41. Wang, H. T., Kong, J. P., Ding, F., Wang, X. Q., Wang, M. R., Liu, L. X., Wu, M. and Liu, Z. H. (2003) Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA microarray. World J. Gastroenterol. 9, 392-398
42. Zinovyeva, M. V., Monastyrskaya, G. S., Kopantzev, E. P., Vinogradova, T. V., Kostina, M. B., Sass, A. V., Filyukova, O. B., Uspenskaya, N. Y., Sukhikh, G. T. and Sverdlov, E. D. (2010) Identification of some human genes oppositely regulated during esophageal squamous cell carcinoma formation and human embryonic esophagus development. Dis. Esophagus 23, 260-270
43. Yu, Y. H., Kuo, H. K. and Chang, K.W. (2008) The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review. PLoS ONE 3, e3215
44. Zhou, Y. B., Huang, Z. X., Ren, C. P., Zhu, B. and Yao, K. T. (2009) Screening and preliminary analysis of the apoptosis- and proliferation-related genes in nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 29, 645-647
45. Zhang, J., Cao, W., Xu, Q. and Chen, W. T. (2010) The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis. J. Clin. Pathol. 64, 25-29